As we prepare to release Issue 5, the next edition of Xtalks Clinical Edge™, our focus remains on the future of clinical trials — offering expert insights, exclusive interviews and strategies to drive innovation in clinical research.
With a highly engaged audience of over 86,000 clinical trial professionals, the magazine is a trusted platform for thought leadership at the intersection of science, technology and patient care.
As the industry moves toward more decentralized, digital and data-driven models, Issue 5 brings together the leaders and innovators who are driving this transformation — offering a comprehensive look at how next-generation clinical research is reshaping the path from concept to cure.
A Look Back: Highlights from Xtalks Clinical Edge™ Issue 4
Issue 4 marked a pivotal moment for Xtalks Clinical Edge™, as we launched a renewed focus on next-generation clinical research — a theme that will continue to define the magazine’s direction. In this edition, readers were immersed in thought-provoking conversations with regulators, digital health pioneers and clinical leaders who are actively shaping the future of trial design and execution.
The issue featured exclusive insights from the FDA’s Center for Drug Evaluation and Research (CDER) on the evolving regulatory landscape for digital health technologies (DHTs), alongside perspectives from the Digital Medicine Society (DiMe) on integrating digital endpoints into modern trial workflows.
Senior leaders from organizations including AstraZeneca, Takeda, Click Therapeutics and Alto Neuroscience contributed practical insights on how innovation is improving patient-centricity, streamlining operations and unlocking new clinical possibilities.
With strong engagement from the clinical research community, Issue 4 reaffirmed the magazine’s role as a valuable resource for industry professionals seeking to stay informed, inspired and ahead of the curve.
What to Expect in Xtalks Clinical Edge™ Issue 5
Building on this momentum, Issue 5 will feature interviews with leaders from big pharma companies, including Amgen, Novartis and AstraZeneca, who share how they’re applying emerging technologies to accelerate development timelines, improve patient experiences and enhance trial efficiency.
We will also highlight insights from small- and mid-sized biotechs like Rivus Pharmaceuticals, Jasper Therapeutics and Plus Therapeutics — innovators tackling complex challenges in cardio-metabolic diseases, mast cell-driven inflammatory conditions and targeted radiotherapeutics for cancer treatment, respectively. These organizations offer a front-row view into the agility, creativity and science-driven strategies fueling the next era of clinical breakthroughs.
Contributors across sectors will reflect on the current state of innovation, the barriers that remain and the opportunities ahead for smarter, faster and more inclusive clinical trials.
Featured Topics in Issue 5
Issue 5 will explore a range of forward-looking topics that are redefining how clinical research is designed, conducted and measured in today’s dynamic landscape:
- Gene Therapies: Exploring the clinical, operational and regulatory considerations involved in advancing gene-based treatments from early development to commercialization
- Artificial Intelligence (AI): Optimizing protocol design, site selection and patient recruitment with data-driven tools
- Decentralized Clinical Trials (DCTs): Enabling greater access and flexibility through hybrid and virtual trial models
- Digital Health Technologies (DHTs): Using sensors, apps and wearables to capture real-world data and validate digital endpoints
- Equity in Trials: Advancing diversity and inclusion through adaptive design and community engagement
Why You Should Be Featured in Xtalks Clinical Edge™
If your organization provides the tools, services or technologies that enable clinical research success — whether you’re a CRO, technology provider, data analytics firm or patient engagement specialist — Xtalks Clinical Edge™ offers a high-impact platform to reach key decision-makers across the clinical trial landscape.
With a variety of editorial and promotional opportunities, your company can:
- Showcase your expertise through sponsored content, Q&As or thought leadership articles developed in collaboration with our Editorial team
- Elevate your brand with visually compelling placements, including full-page image ads
Position your organization as a trusted enabler of next-gen clinical research — and increase your visibility among the stakeholders driving innovation in the industry.
Partner With Us
To explore how your organization can be featured in the next issue, connect with:
Gabriela Bravo, Global Director, Value Added Services, Xtalks
Email: [email protected]
Phone: +1 289-306-0359
Shape the Future of Clinical Trials with Xtalks Clinical Edge™
From cutting-edge technologies to real-world operational strategies, Xtalks Clinical Edge™ Issue 5 brings together the insights that matter most.
Join us as we continue to spotlight the people and ideas driving clinical research forward — and be part of the conversation redefining the next generation of trials.
Join or login to leave a comment
JOIN LOGIN